![Uri Lopatin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uri Lopatin
Vorstandsvorsitzender bei
Ukko Inc.
Profil
Uri A. Lopatin was the founder of Assembly Pharmaceuticals, Inc., founded in 2012, serving as Chief Medical Officer & VP-Research & Development.
Dr. Lopatin was the founder of Assembly Biosciences, Inc., founded in 2005, serving as Scientific & Strategic Advisor from 2019 to 2022.
Dr. Lopatin was the founder of Pardes Biosciences, Inc., founded in 2020, serving as Director from 2022 to 2023.
Dr. Lopatin is currently Chief Executive Officer at Ukko, Inc. since 2024 and Operating Partner at Khosla Ventures LLC since 2023.
Former positions include Director-Clinical & Translational Research at Gilead Sciences, Inc. from 2010 to 2012 and Associate Director at Schering-Plough Research Institute from 2007 to 2008.
Education includes graduate and undergraduate degrees from Cornell University in 1994, a graduate degree from New York University in 2003, a graduate degree from UW Medicine in 2001, a doctorate from New Jersey Medical School in 2000, and a graduate degree from National Institutes of Health in 2006.
Aktive Positionen von Uri Lopatin
| Unternehmen | Position | Beginn |
|---|---|---|
Khosla Ventures LLC
 Khosla Ventures LLC Investment ManagersFinance Khosla Ventures invests in companies located in the United States with transaction size that exceed USD 10 million. The firm targets companies operating across a broad range of sectors and industries. It participates in seed, early and later stage capital requirements with an revenue ranging from USD 50 to 150 million. | Private Equity Investor | 01.08.2023 |
Ukko Inc.
 Ukko Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company which provides solutions for people who suffer from food allergies and disorders | Vorstandsvorsitzender | 01.11.2024 |
Ehemalige bekannte Positionen von Uri Lopatin
| Unternehmen | Position | Ende |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Gründer | 30.08.2023 |
| ASSEMBLY BIOSCIENCES, INC. | Gründer | 01.03.2022 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.09.2012 |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Private Equity Investor | 01.04.2008 |
Assembly Pharmaceuticals, Inc.
 Assembly Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies biopharmaceutical products | Gründer | - |
Ausbildung von Uri Lopatin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Khosla Ventures LLC
Khosla Ventures LLC Investment ManagersFinance Khosla Ventures invests in companies located in the United States with transaction size that exceed USD 10 million. The firm targets companies operating across a broad range of sectors and industries. It participates in seed, early and later stage capital requirements with an revenue ranging from USD 50 to 150 million. | Finance |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Health Technology |
UW Medicine
 UW Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Jersey Medical School
 New Jersey Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Assembly Pharmaceuticals, Inc.
Assembly Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies biopharmaceutical products | Health Technology |
Assembly Biosciences, Inc.
 Assembly Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of products for infectious diseases | Health Technology |
Ukko Inc.
Ukko Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company which provides solutions for people who suffer from food allergies and disorders | Commercial Services |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
National Institutes of Health
 National Institutes of Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
